The article says slow escalation helps providers distinguish true hypersensitivity from expected adaptive side effects that resolve within one to two weeks
Sergey Terushkin, MD, FACS Gastrointestinal side effects are the main reason some patients consider stopping treatment early
In discussions around GLP 1 therapies, Huberman consistently points out that while pharmacology can drive significant fat loss, long term outcomes still depend on training, nutrition, and lifestyle structure
Culturally, GLP-1s are accelerating a reframing of weight as a biological and systemic issue rather than a moral one
Back home, scrolling online, you may come across a buzzy new GLP-1 that costs $100 for a month's supply, and supposedly preserves muscle while melting fat